Aurora-A expression, hormone receptor status and clinical outcome in hormone related cancers

References

• Kurman RJ, Shih IeM. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 2008; 27: 151–160.
   PubMed Web of Science ®Google Scholar
• Galli MC, De Giovanni C, Nicoletti G, et al The occurrence of multiple steroid hormone receptors in disease-free and neoplastic human ovary. Cancer 1981; 47: 1297–1302.
   Google Scholar
• Slotman BJ, Rao BR. Ovarian cancer. Etiology, diagnosis, prognosis, surgery, radiotherapy, chemotherapy and endocrine therapy. Anticancer Res 1988; 8: 417–434.
   PubMed Web of Science ®Google Scholar
• Berger CW vDH, van der Valk P, Bonfrer HMG. Oestrogen, progesterone and androgen receptors in ovarian neoplasm; correlation between immunohistochemical and biochemical receptor analysis. Int J Gynecol Cancer 1999; 9: 17.
   Google Scholar
• Miller WRLS. Steroid hormones and cancer: (II) lessons from experimental system. Eur J Surg Oncol 1997; 23: 72–83.
   PubMedGoogle Scholar
• Hemminki K, Granstrom C. Morphological types of breast cancer in family members and multiple primary tumours: is morphology genetically determined? Breast Cancer Res 2002; 4: R7.
   Google Scholar
• Das K, Leong DT, Gupta A, et al Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer. Eur J Cancer 2009; 45: 2239–2248.
   Google Scholar
• Sakr WA, Partin AW. Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia. Urology 2001; 57: 115–120.
   PubMed Web of Science ®Google Scholar
• Debes JD, Tindall DJ. Mechanisms of androgen-refractory prostate cancer. N Engl J Med 2004; 351: 1488–1490.
   PubMed Web of Science ®Google Scholar
• Li JJ, Weroha SJ, Lingle WL, et al Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats. Proc Natl Acad Sci USA 2004; 101: 18123–18128.
   PubMedGoogle Scholar
• Jallepalli PV, Lengauer C. Chromosome segregation and cancer: cutting through the mystery. Nat Rev Cancer 2001; 1: 109–117.
   PubMed Web of Science ®Google Scholar
• Keen N, Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer 2004; 4: 927–936.
   PubMed Web of Science ®Google Scholar
• Dutertre S, Descamps S, Prigent C. On the role of aurora-A in centrosome function. Oncogene 2002; 21: 6175–6183.
   PubMed Web of Science ®Google Scholar
• Marumoto T, Zhang D, Saya H. Aurora-A – a guardian of poles. Nat Rev Cancer 2005; 5: 42–50.
   PubMed Web of Science ®Google Scholar
• Landen CN Jr, Lin YG, Immaneni A, et al Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients. Clin Cancer Res 2007; 13: 4098–4104.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Kimura M, Matsunaga K, et al Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res 1999; 59: 2041–2044.
   PubMed Web of Science ®Google Scholar
• Lee EC, Frolov A, Li R, et al Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res 2006; 66: 4996–5002.
   PubMed Web of Science ®Google Scholar
• Chung CM, Man C, Jin Y, et al Amplification and overexpression of aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells. Mol Carcinog 2005; 43: 165–174.
   PubMed Web of Science ®Google Scholar
• Mendiola M, Barriuso J, Marino-Enriquez A, et al Aurora kinases as prognostic biomarkers in ovarian carcinoma. Hum Pathol 2009; 40: 631–638.
   Google Scholar
• Ewart-Toland A, Briassouli P, de Koning JP, et al Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet 2003; 34: 403–412.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhou YX, Qiao W, et al Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene 2006; 25: 7148–7158.
   PubMed Web of Science ®Google Scholar
• Yang H, Ou CC, Feldman RI, et al Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells. Cancer Res 2004; 64: 463–467.
   PubMed Web of Science ®Google Scholar
• Buschhorn HM, Klein RR, Chambers SM, et al Aurora-A over-expression in high-grade PIN lesions and prostate cancer. Prostate 2005; 64: 341–346.
   PubMed Web of Science ®Google Scholar
• Das K, Lau W, Sivaswaren C, et al Chromosomal changes in prostate cancer: a fluorescence in situ hybridization study. Clin Genet 2005; 68: 40–47.
   Google Scholar
• Das K, Mohd Omar MF, Ong CW, et al TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery. Pathology 2008; 40: 441–449.
   Web of Science ®Google Scholar
• Zhang D, Salto-Tellez M, Putti TC, et al Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer. Mod Pathol 2003; 16: 79–84.
   PubMed Web of Science ®Google Scholar
• Hoque A, Carter J, Xia W, et al Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. Cancer Epidemiol Biomarkers Prev 2003; 12: 1518–1522.
   PubMed Web of Science ®Google Scholar
• Miyoshi Y, Iwao K, Egawa C, et al Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int J Cancer 2001; 92: 370–373.
   PubMed Web of Science ®Google Scholar
• Ito K, Liu Q, Salto-Tellez M, et al RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res 2005; 65: 7743–7750.
   PubMedGoogle Scholar
• Lau QC, Raja E, Salto-Tellez M, et al RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res 2006; 66: 6512–6520.
   PubMed Web of Science ®Google Scholar
• Berdnik D, Knoblich JA. Drosophila Aurora-A is required for centrosome maturation and actin-dependent asymmetric protein localization during mitosis. Curr Biol 2002; 12: 640–647.
   PubMed Web of Science ®Google Scholar
• Mori D, Yano Y, Toyo-oka K, et al NDEL1 phosphorylation by Aurora-A kinase is essential for centrosomal maturation, separation, and TACC3 recruitment. Mol Cell Biol 2007; 27: 352–367.
   PubMedGoogle Scholar
• Gritsko TM, Coppola D, Paciga JE, et al Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin Cancer Res 2003; 9: 1420–1426.
   PubMed Web of Science ®Google Scholar
• Jeng YM, Peng SY, Lin CY, et al Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res 2004; 10: 2065–2071.
   PubMed Web of Science ®Google Scholar
• Nadler Y, Camp RL, Schwartz C, et al Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer. Clin Cancer Res 2008; 14: 4455–4462.
   PubMed Web of Science ®Google Scholar
• Hontz AE, Li SA, Lingle WL, et al Aurora a and B overexpression and centrosome amplification in early estrogen-induced tumor foci in the Syrian hamster kidney: implications for chromosomal instability, aneuploidy, and neoplasia. Cancer Res 2007; 67: 2957–2963.
   PubMed Web of Science ®Google Scholar
• Yang SB, Zhou XB, Zhu HX, et al Amplification and overexpression of Aurora-A in esophageal squamous cell carcinoma. Oncol Rep 2007; 17: 1083–1088.
   PubMed Web of Science ®Google Scholar
• Lassmann S, Shen Y, Jutting U, et al Predictive value of Aurora-A/STK15 expression for late stage epithelial ovarian cancer patients treated by adjuvant chemotherapy. Clin Cancer Res 2007; 13: 4083–4091.
   Google Scholar
• Yang H, He L, Kruk P, et al Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. Int J Cancer 2006; 119: 2304–2312.
   PubMed Web of Science ®Google Scholar